Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 23796867)

1.

Factors influencing discordant results of the QuantiFERON-TB Gold In-tube test in patients with active TB.

Jeon YL, Nam YS, You E, Yang JJ, Kim MJ, Cho SY, Park TS, Lee HJ.

J Infect. 2013 Oct;67(4):288-93. doi: 10.1016/j.jinf.2013.06.005. Epub 2013 Jun 22.

PMID:
23796867
2.

Risk factors for false-negative results of QuantiFERON-TB Gold In-Tube assay in non-HIV-infected patients with culture-confirmed tuberculosis.

Kim EY, Park MS, Kim YS, Kim SK, Chang J, Kang YA.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):324-9. doi: 10.1016/j.diagmicrobio.2011.02.011. Epub 2011 May 4.

PMID:
21546200
3.

Factors influencing discrepancies between the QuantiFERON-TB gold in tube test and the tuberculin skin test in Korean patients with rheumatic diseases.

Kim JH, Cho SK, Han M, Choi CB, Kim TH, Jun JB, Bae SC, Yoo DH, Sung YK.

Semin Arthritis Rheum. 2013 Feb;42(4):424-32. doi: 10.1016/j.semarthrit.2012.07.001. Epub 2012 Aug 2.

PMID:
22858451
4.

Significant reduction in rate of indeterminate results of the QuantiFERON-TB Gold In-Tube test by shortening incubation delay.

Yun JW, Chung HS, Koh WJ, Chung DR, Kim YJ, Kang ES.

J Clin Microbiol. 2014 Jan;52(1):90-4. doi: 10.1128/JCM.01547-13. Epub 2013 Oct 23.

5.

Effect of prolonged incubation time on results of the QuantiFERON TB gold in-tube assay for diagnosis of latent tuberculosis infection.

Min JW, Lee HY, Lee JS, Lee J, Chung JH, Han SK, Yim JJ.

Clin Vaccine Immunol. 2013 Sep;20(9):1377-80. doi: 10.1128/CVI.00290-13. Epub 2013 Jul 3.

6.

Factors Associated with Indeterminate and False Negative Results of QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis.

Cho K, Cho E, Kwon S, Im S, Sohn I, Song S, Kim H, Kim S.

Tuberc Respir Dis (Seoul). 2012 May;72(5):416-25. doi: 10.4046/trd.2012.72.5.416. Epub 2012 May 29.

7.

Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis.

Santin M, Muñoz L, Rigau D.

PLoS One. 2012;7(3):e32482. doi: 10.1371/journal.pone.0032482. Epub 2012 Mar 5. Review.

9.

Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.

Pullar ND, Steinum H, Tonby K, Heggelund L, Leiva RA, Ofstad R, Bruun JN, Dyrhol-Riise AM.

Int J Tuberc Lung Dis. 2014 Feb;18(2):180-7. doi: 10.5588/ijtld.13.0276.

PMID:
24429310
10.

Diagnostic performance of whole-blood interferon-γ assay and enzyme-linked immunospot assay for active tuberculosis'.

Lai CC, Tan CK, Lin SH, Liao CH, Huang YT, Hsueh PR.

Diagn Microbiol Infect Dis. 2011 Oct;71(2):139-43. doi: 10.1016/j.diagmicrobio.2011.05.013. Epub 2011 Aug 15.

PMID:
21840675
11.

Conversion rates of an interferon-γ release assay and the tuberculin skin test in the serial monitoring of healthcare workers.

Kim SY, Park MS, Kim YS, Kim SK, Chang J, Kang YA.

Infection. 2013 Apr;41(2):511-6. doi: 10.1007/s15010-012-0356-0. Epub 2012 Oct 27.

PMID:
23104257
12.

Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response.

Sauzullo I, Mengoni F, Ermocida A, Massetti AP, D'Agostino C, Russo G, Salotti A, Falciano M, Vullo V, Mastroianni CM.

New Microbiol. 2014 Apr;37(2):153-61. Epub 2014 Apr 1.

13.

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.

Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Melchiorre D, Tortoli E, Mantella A, Benucci M, Girardi E, Cerinic MM, Bartoloni A.

Eur Respir J. 2009 Mar;33(3):586-93. doi: 10.1183/09031936.00107608. Epub 2008 Dec 1.

14.

Serial interferon-gamma release assays during treatment of active tuberculosis in young adults.

Lee SW, Lee CT, Yim JJ.

BMC Infect Dis. 2010 Oct 16;10:300. doi: 10.1186/1471-2334-10-300.

15.

The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.

Chen YM, Chen HH, Lai KL, Hung WT, Lan JL, Chen DY.

Rheumatology (Oxford). 2013 Apr;52(4):697-704. doi: 10.1093/rheumatology/kes365. Epub 2012 Dec 22.

16.

Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.

Sauzullo I, Mengoni F, Scrivo R, Valesini G, Potenza C, Skroza N, Marocco R, Lichtner M, Vullo V, Mastroianni CM.

Int J Tuberc Lung Dis. 2010 Jul;14(7):834-40.

PMID:
20550765
17.

Diagnostic performance of the QuantiFERON-TB Gold In-Tube assay and factors associated with nonpositive results in patients with miliary tuberculosis.

Kim CH, Lim JK, Yoo SS, Lee SY, Cha SI, Park JY, Lee J.

Clin Infect Dis. 2014 Apr;58(7):986-9. doi: 10.1093/cid/ciu045. Epub 2014 Jan 22.

18.

[Interpreting "equivocal" results obtained from the QuantiFERON-TB Gold In-Tube test in contact investigations].

Komukai J, Matsumoto K, Hirota S, Yoshida H, Koda S, Terakawa K, Shimouchi A.

Kekkaku. 2013 Mar;88(3):301-4. Japanese.

PMID:
23672171
19.

Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals.

Aichelburg MC, Rieger A, Breitenecker F, Pfistershammer K, Tittes J, Eltz S, Aichelburg AC, Stingl G, Makristathis A, Kohrgruber N.

Clin Infect Dis. 2009 Apr 1;48(7):954-62. doi: 10.1086/597351.

20.

Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.

Ringshausen FC, Nienhaus A, Schablon A, Schlösser S, Schultze-Werninghaus G, Rohde G.

BMC Infect Dis. 2010 Jul 23;10:220. doi: 10.1186/1471-2334-10-220.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk